Roivant Sciences (ROIV) Net Income towards Common Stockholders (2020 - 2024)

Roivant Sciences' Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at $373.2 million for Q4 2024.

• Quarterly Net Income towards Common Stockholders rose 264.66% year-over-year to $373.2 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $373.2 million (up 306.6% YoY) and the FY2025 annual result came in at $373.2 million, up 218.42% from the prior year.
• Net Income towards Common Stockholders was $373.2 million for Q4 2024 at Roivant Sciences, up from -$43.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $373.2 million in Q4 2024 and bottomed at -$1.1 billion in Q4 2022.
• A 5-year average of -$216.2 million and a median of -$225.6 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders slumped 1167.12% — and 2024, when it surged 264.66%.
• Roivant Sciences' Net Income towards Common Stockholders stood at -$275.6 million in 2020, then plunged by 129.61% to -$632.8 million in 2021, then sank by 66.66% to -$1.1 billion in 2022, then jumped by 78.51% to -$226.6 million in 2023, then jumped by 264.66% to $373.2 million in 2024.
• Business Quant data shows ROIV's Net Income towards Common Stockholders at $373.2 million in Q4 2024, -$43.1 million in Q3 2024, and $89.1 million in Q2 2024.